INSIGHTEC, a global healthcare therapeutics company, has received funding from England’s public healthcare provider for their neurological disorder treatment, one that effects 41 million people globally. The treatment utilized acoustic sound energy, a trademark of INSIGHTEC, to target the area of the brain responsible for the progressively debilitating tremor.
Learn more here.
More on: News Regulatory